1-7 of 7
flt3 inhibitors
Close
Sort by
Journal Articles

The growing landscape of FLT3 inhibition in AML

Catherine C. Smith
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 539–547.
https://doi.org/10.1182/hematology.2019000058
Published: 2019
Journal Articles

Single-agent and combination biologics in acute myeloid leukemia

Guillaume Richard-Carpentier, Courtney D. DiNardo
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 548–556.
https://doi.org/10.1182/hematology.2019000059
Published: 2019
Journal Articles

The role of targeted therapy in the management of patients with AML

Alexander E. Perl
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 54–65.
https://doi.org/10.1182/asheducation-2017.1.54
Published: 2017
Journal Articles

FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?

Mark Levis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 220–226.
https://doi.org/10.1182/asheducation-2013.1.220
Published: 2013
Journal Articles

FLT3 Mutations: Biology and Treatment

Donald Small
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 178–184.
https://doi.org/10.1182/asheducation-2006.1.178
Published: 2006
Journal Articles

The Biology of Acute Promyelocytic Leukemia and Its Impact on Diagnosis and Treatment

Francesco Lo-Coco, Emanuele Ammatuna
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 156–161.
https://doi.org/10.1182/asheducation-2006.1.156
Published: 2006
Journal Articles

New Strategies for the Treatment of Acute Myeloid Leukemia Including Antibodies and Other Novel Agents

Martin S. Tallman
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 143–150.
https://doi.org/10.1182/asheducation-2005.1.143
Published: 2005